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Abstract
Background: Rising rates of obesity and type 2 diabetes (T2D) are impending major threats to the health of African
populations, but the extent to which they differ between rural and urban settings in Africa and upon migration to
Europe is unknown. We assessed the burden of obesity and T2D among Ghanaians living in rural and urban Ghana
and Ghanaian migrants living in different European countries.
Methods: A multi-centre cross-sectional study was conducted among Ghanaian adults (n = 5659) aged 25–70 years
residing in rural and urban Ghana and three European cities (Amsterdam, London and Berlin). Comparisons
between groups were made using prevalence ratios (PRs) with adjustments for age and education.
Results: In rural Ghana, the prevalence of obesity was 1.3 % in men and 8.3 % in women. The prevalence was
considerably higher in urban Ghana (men, 6.9 %; PR: 5.26, 95 % CI, 2.04–13.57; women, 33.9 %; PR: 4.11, 3.13–5.40)
and even more so in Europe, especially in London (men, 21.4 %; PR: 15.04, 5.98–37.84; women, 54.2 %; PR: 6.63, 5.04–8.72).
The prevalence of T2D was low at 3.6 % and 5.5 % in rural Ghanaian men and women, and increased in urban
Ghanaians (men, 10.3 %; PR: 3.06; 1.73–5.40; women, 9.2 %; PR: 1.81, 1.25–2.64) and highest in Berlin (men, 15.3 %;
PR: 4.47; 2.50–7.98; women, 10.2 %; PR: 2.21, 1.30–3.75). Impaired fasting glycaemia prevalence was comparatively
higher only in Amsterdam, and in London, men compared with rural Ghana.
Conclusion: Our study shows high risks of obesity and T2D among sub-Saharan African populations living in Europe.
In Ghana, similarly high prevalence rates were seen in an urban environment, whereas in rural areas, the prevalence
of obesity among women is already remarkable. Similar processes underlying the high burden of obesity and T2D
following migration may also be at play in sub-Saharan Africa as a consequence of urbanisation.
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Background
Type 2 diabetes mellitus constitutes a growing threat to
human health. The International Diabetes Federation re-
cent estimates indicate that 9 % of the global adult
population (415 million people) have diabetes, with the
number set to rise beyond 642 million within the next
two decades [1]. The diabetes epidemic is truly a global
problem with substantial variations within regions.
In high-income countries, migrant populations are par-
ticularly affected by type 2 diabetes [2]. They also develop
type 2 diabetes at a younger age, and have higher associ-
ated morbidity and mortality and related complications,
such as cardiovascular disease, than local European popu-
lations [3–5]. The limited data available indicate that sub-
Saharan African (SSA) migrants are among those that are
most affected by type 2 diabetes [2, 3]. In a recent meta-
analysis, the prevalence of type 2 diabetes was nearly three
times higher in populations of SSA origin than in
European host populations [2]. In addition, the prevalence
of type 2 diabetes differs between SSA origin populations
living in different European countries. In a previous study,
the prevalence of type 2 diabetes was higher among
African Caribbeans living in England than in African
Caribbeans living in the Netherlands [6]. This suggest that
distinct environmental factors, in addition to heritable
susceptibility, contribute to the development of type 2 dia-
betes among these populations.
The prevalence of type 2 diabetes is not only rising
among migrants, but also in low- and middle-income
countries such as those in SSA from where many of these
populations originate [7, 8]. While type 2 diabetes seemed
to be virtually absent, for example, in West Africa in the
1960s and 1980s, today it has become a major health
threat particularly in urban centres [7, 8]. SSA is expected
to experience the worldwide fastest increase in the num-
ber of people living with type 2 diabetes (141 %) in the
next two decades [1]. The rising levels of type 2 diabetes
in populations of SSA origin are a reflection of the rising
levels of major risk factors such as obesity [9, 10].
The rising levels of obesity and associated type 2
diabetes among SSA origin populations is thought to be a
result of transitioning of societies, and resulting changes
in lifestyles, though the key specific drivers within this
broad category still need to be determined [1, 9]. Migra-
tion studies provide important windows of opportunity to
assess differences between migrating and non-migrating
populations, and to help identify the potential factors driv-
ing the rising levels of type 2 diabetes and obesity among
these populations. Such knowledge is a prerequisite for
designing effective public health interventions for address-
ing the problem. Ideally, this requires comparing a rela-
tively homogeneous migrant population with the source
population in their country of origin in Africa. However,
such data are lacking so far. Consequently, in the last two
decades, studies have used migration surrogates such as
multinational comparison of African descent populations
living in diverse geographic environments [11, 12]. The
findings, however, are difficult to interpret because of the
heterogeneous nature of the African populations studied
so far, and the reliance on secondary analyses of data from
different studies.
The main aim of this paper was, therefore, to compare
the prevalence of obesity and type 2 diabetes among Gha-
naians living in rural and urban Ghana, as well as among
Ghanaians living in three different European countries.
Methods
Study population and study design
The RODAM (acronym for Research on Obesity & Diabetes
among African Migrants) study is a multi-centre cross-
sectional study. The rationale, conceptual framework, design
and methodology of the RODAM study have been described
in detail elsewhere [13]. In brief, the study was carried out
between 2012 and 2015 and it included Ghanaians aged 25–
70 years living in rural and urban Ghana as well as in
Amsterdam, Berlin and London. As a central feature of the
RODAM study, at all study sites, a well standardised ap-
proach was used for data collection. Previous studies among
African communities in Europe showed that involvement of
the community leaders improves study participation [14, 15].
The RODAM study, therefore, involved the Ghanaian com-
munity leaders in all the five geographical sites.
In Ghana, two purposively chosen cities and 15 villages in
the Ashanti region were used as the urban and rural recruit-
ment sites, respectively. Participants were randomly drawn
from the list of 30 enumeration areas in the Ashanti region
based on the 2010 census. In Amsterdam, Ghanaian partici-
pants were randomly drawn from the Amsterdam Munici-
pal Health register, which holds data on country of birth of
citizens and their parents, thus allowing for sampling based
on the Dutch standard indicator for ethnic origin. In
London, there was no population register for migrant
groups. Consequently, Ghanaian organisations served as the
sampling frame. Lists of these organisations were obtained
from the Ghanaian Embassy and the Association of Ghan-
aian Churches in the UK in the boroughs known to have
the greatest concentration of Ghanaians. Lists of all mem-
bers of their organisations were also requested. In Berlin, a
list of Ghanaian individuals was provided by the registration
office of the federal state of Berlin, but due to low response
to written invitation based on this list, we changed to mem-
ber lists of Ghanaian churches and organisations as the sam-
pling frame. In all European sites, all selected participants
from these lists were sent a written invitation combined with
written information regarding the study and a response card.
After a positive response, the participants were contacted by
phone to schedule date and location of the interview with a
trained research assistant or opt for the self-administration
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of the paper questionnaire or digital online version depend-
ing on the preference of the participant. Subsequent to the
completion of the questionnaire, a date for physical examin-
ation was then scheduled. All the participants were
instructed to fast from 10.00 pm the night prior to the phys-
ical examination.
The participation rate was 76 % in rural Ghana and
74 % in urban Ghana. In London, of those individuals that
were registered in the various Ghanaian organisations and
were invited, 75 % agreed and participated in the study. In
Berlin, this figure was 68 %. In Amsterdam, we received a
response from 67 % of those invited, either by response
card or after a home visit by an ethnically-matched inter-
viewer. Of these, 53 % agreed and participated in the
study. Almost all of the Ghanaians in Europe were first
generation (99 %) migrants, and the mean length of stay
was generally similar across the three European sites.
Measurements
Information on demographics, education level, medical
history, treatment and lifestyle factors was obtained by
questionnaire. Physical examinations were performed
with validated devices according to standardised oper-
ational procedures across all study sites. Weight was
measured in light clothing and without shoes with SECA
877 scales to the nearest 0.1 kg. Height was measured
without shoes with a portable stadiometer (SECA 217)
to the nearest 0.1 cm. Body mass index (BMI) was calcu-
lated as weight (kg) divided by height squared (m2).
Overweight was defined as a BMI of ≥ 25 to < 30 kg/m2
and obesity as a BMI ≥ 30 kg/m2 [16]. Waist circumference
was measured in centimetres at the midpoint between the
lower rib and the upper margin of the iliac crest.
Abdominal obesity was defined according to World Health
Organization cut-offs: waist circumference > 102 cm in
men and > 88 cm in women [16]. All the anthropometrics
were measured twice by the same assessor and the average
of the two measurements were used for analyses. Blood
pressure was measured three times using a validated semi-
automated device (The Microlife WatchBP home) with ap-
propriate cuffs in a sitting position after at least 5 min rest.
The mean of the last two blood pressure measurements
was used in the analyses.
Fasting venous blood samples were collected by trained
research assistants in all sites. All the blood samples were
processed and aliquoted immediately (within 1 hour to
maximum 3 hours of the vena puncture) after collection
according to standard operation procedures, and then
temporarily stored at the local research location at −20 °C.
The separated samples were then transported to the local
research centres’ laboratories, where they were checked,
registered and stored at −80 °C. To avoid intra-laboratory
variability, the stored blood samples from the local re-
search centres were transported to Berlin for biochemical
analyses. Fasting plasma glucose concentration was mea-
sured using an enzymatic method (hexokinase). Con-
centration of total cholesterol was assessed by using
colorimetric test kits. All biochemical analyses were per-
formed by using an ABX Pentra 400 chemistry analyzer
(ABX Pentra; Horiba ABX, Germany). Type 2 diabetes
was defined according to the World Health Organization
diagnostic criteria (fasting glucose ≥ 7.0 mmol/L, or
current use of medication prescribed to treat diabetes, or
self-reported diabetes) [17]. Impaired fasting glycaemia
(IFG) was defined as fasting glucose of between 5.6 and
6.9 mmol/L according to the American Diabetes Associ-
ation definition as this threshold optimises sensitivity and
specificity for predicting future diabetes [18].
Data analysis
The characteristics of the study population were
expressed as percentages with 95 % confidence intervals
(CI) for categorical variables and means with 95 % CIs
for continuous variables. Age-standardised prevalence
rates of obesity, type 2 diabetes and IFG were calculated
using the direct method, with the standards being the
age distribution of the total RODAM population [19].
Prevalence ratios (PR) and their corresponding 95 % CIs
were estimated by means of Poisson regression with
robust variance to examine differences in prevalence
between rural Ghanaians and their Ghanaian compa-
triots living in urban Ghana and the various European
countries, respectively, with adjustment for age and edu-
cation. Probabilities of type 2 diabetes and obesity by
age, BMI and waist circumference were plotted using
marginal effects of continuous predictors (MCP) com-
mand in STATA. All analyses were performed using
STATA 14.0 (Stata Corp, College Station, Texas).
Results
Characteristics of the study population
Out of the 6385 Ghanaians who agreed and participated,
5659 were included in the analysis after exclusion of
those who did not participate in the physical examin-
ation, those without blood samples collected and those
outside the age range (Additional file 1: Figure S1). The
age structure was similar in all geographical sites,
although men in Amsterdam and Berlin were slightly
older than in other geographical sites. Ghanaians in
London were the most educated group while individuals
from rural Ghana were the least educated group (Table 1).
There were substantial differences in mean BMI, waist cir-
cumference, fasting glucose, total cholesterol and blood
pressure among sites, with individuals in urban Ghana
and Europe having higher mean levels than their counter-
parts in rural Ghana. Smoking prevalence was higher in
Berlin and Amsterdam than in other sites.
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Prevalence of obesity
The age-standardised prevalence of generalised obesity var-
ied between the five population groups, ranging from 1 %
in rural Ghana to 21 % in London in men, and from 8 % in
rural Ghana to 54 % in London in women (Fig. 1a, b).
Similar large differences were also observed for abdominal
obesity with the age-standardised prevalence rates in men,
ranging from 2 % in rural Ghana to 18 % in Amsterdam,
and in women from 31 % in rural Ghana to 76 % in
London (Fig. 2a, b). The differences between individuals
Table 1 Characteristics of the population by locality and sex
Rural Ghanaians Urban Ghanaians Amsterdam Ghanaians Berlin Ghanaians London Ghanaians
Men (n = 405) (n = 415) (n = 609) (n = 297) (n = 410)
Age, years 46.2 (45.0–47.5) 46.5 (45.4–47.7) 48.4 (47.7–49.2) 45.8 (44.6–47.0) 46.1 (45.0–47.1)
Education level, %
None or elementary 39.0 (34.4–43.8) 22.2 (18.4–26.4) 20.5 (17.5–23.9) 6.1 (3.9–9.4) 3.9 (2.4–6.3)
Lower secondary 36.1 (31.5–40.9) 42.4 (37.7–47.2) 40.6 (36.7–44.5) 47.8 (42.2–53.5) 24.9 (20.9–29.3)
Higher secondary 13.3 (10.4–17.0) 20.5 (16.9–24.6) 25.1 (21.8–28.7) 28.3 (23.4–33.7) 16.8 (13.5–20.8)
Tertiary education 5.7 (3.8–8.4) 9.2 (6.7–12.3) 8.2 (6.2–10.7) 17.5 (13.6–22.3) 41.0 (36.3–45.8)
Unknown 5.9 (4.0–8.7) 5.8 (6.9–8.5) 5.6 (4.0–7.7) 0.3 (0.0–2.4) 13.4 (10.4–17.7)
Length of stay in Europe, years NA NA 18.7 (18.0–19.4) 16.8 (15.5–18.2) 15.1 (14.1–16.1)
First generation migrants, % NA NA 98.6 (97.1–99.3) 99.3 (97.2–99.9) 98.6 (96.7–99.4)
Current smoking, yes, % 5.8 (3.8–8.6) 3.3 (1.9–5.6) 8.1 (6.1–10.7) 14.8 (11.2–19.3) 1.4 (1.0–3.2)
BMI, kg/m2 20.9 (20.6–21.2) 24.1 (23.8–24.5) 27.0 (26.7–27.3) 26.4 (26.0–26.9) 27.5 (27.1–27.9)
Waist, cm 76.8 (76.0–77.6) 84.7 (83.7–85.7) 91.1 (87.2–95.1) 91.2 (89.9–92.5) 75.3 (61.2–89.4)
Total cholesterol, mmol/L 4.2 (4.1–4.3) 5.1 (5.0–5.2) 5.1 (5.0–5.1) 5.2 (5.0–5.3) 5.0 (4.9–5.1)
Fasting glucose, mmol/L 5.1 (5.0–5.2) 5.8 (5.5–6.0) 5.7 (5.5–5.9) 5.5 (5.2–5.7) 5.3 (5.2–5.5)
Systolic BP, mmHg 123.9 (122.0–125.7) 131.0 (129.0–133.0) 138.2 (136.8–139.6) 138.9 (136.8–141.0) 136.6 (134.9–138.3)
Diastolic BP, mmHg 77.4 (76.3–78.4) 82.2 (81.0–83.5) 87.9 (87.0–88.8) 88.7 (87.4–90.0) 84.6 (83.6–85.7)
Known diabetes, % 1.2 (0.5–2.9) 7.0 ( 4.9–9.9) 11.7 (9.3–14.5) 12.8 (9.4–17.1) 7.6 (5.4–10.6)
Newly detected diabetes, % 2.0 (1.0–3.9) 3.9 (2.4–6.2) 2.1 (1.2–3.6) 2.7 (1.4–5.3) 2.2 (1.1–4.2)
Women (n = 638) (n = 1034) (n = 931) (n = 250) (n = 670)
Age, years 46.7 (45.7–47.6) 44.7 (44.1–45.4) 45.6 (45.0–46.1) 44.7 (43.5–45.8) 47.7 (46.9–48.5)
Education level, %
None or elementary 62.2 (58.4–65.9) 50.5 (47.5–53.6) 40.8 (37.7–44.0) 11.6 (8.2–16.2) 10.0 (8.0–12.5)
Lower secondary 26.0 (22.8–29.6) 35.9 (33.0–38.9) 30.7 (27.8–33.7) 54.0 (47.8–60.1) 28.9 (26.5–33.4)
Higher secondary 3.0 (1.9–4.6) 8.5 (7.0–10.4) 17.9 (15.5–20.5) 24.8 (19.8–30.5) 24.2 (21.1–27.6)
Tertiary education 1.9 (1.1–3.3) 2.7 (1.9–3.9) 3.8 (2.7–5.2) 7.6 (4.9–11.6) 22.1 (19.1–25.3)
Unknown 6.9 (5.2–9.2) 2.3 (1.6–3.4) 6.9 (5.4–8.7) 6.9 (5.4–8.7) 2.0 (1.0–4.7)
Length of stay in Europe, years NA NA 17.7 (17.2–18.2) 16.9 (15.7–18.2) 17.4 (16.5–18.3)
First generation migrants, % NA NA 99.5 (98.8–99.8) 99.6 (97.2–99.9) 96.9 (95.2–98.1)
Current smoking, yes, % 0.0 (0.0–0.1) 0.1 (0.0–1.0) 2.1 (1.3–3.4) 3.3 (1.6 (6.3) 0.2 (0.0–1.2)
BMI, kg/m2 23.7 (23.3–24.0) 28.0 (27.7–28.3) 30.3 (30.0–30.6) 29.1 (28.5–29.7) 30.9 (30.5–31.3)
Waist, cm 81.9 (78.2–85.7) 90.0 (87.6–92.4) 94.7 (92.0–97.4) 93.7 (92.3–95.1) 80.4 (69.8–91.0)
Total cholesterol, mmol/L 4.7 (4.6–4.8) 5.3 (5.2–5.3) 5.0 (4.9–5.1) 5.1 (5.0–5.3) 5.0 (4.9–5.1)
Fasting glucose, mmol/L 5.2 (5.1–5.3) 5.5 (5.4–5.7) 5.4 (5.3–5.4) 4.8 (4.7–5.0) 5.2 (5.1–5.3)
Systolic BP, mmHg 123.7 (122.0–125.5) 124.7 (123.5–125.9) 131.9 (130.8–133.0) 132.0 (129.7–134.3) 134.4 (133.1–135.7)
Diastolic BP, mmHg 76.9 (76.0–77.9) 78.3 (77.6–79.0) 82.0 (81.4–82.7) 83.6 (82.2–85.0) 82.3 (81.5–83.0)
Known diabetes, % 3.3 (2.2–5.0) 4.9 (3.8–6.4) 8.3 (6.7–10.2) 8.8 (5.9–13.0) 7.0 (5.3–9.2)
Newly detected diabetes, % 2.4 (1.4–3.9) 3.5 (2.5–4.8) 1.0 (0.5–1.8) 0.8 (0.2–3.2) 1.8 (1.0–3.1)
Values are means or percentages with corresponding 95 % confidence intervals
BP, blood pressure; BMI, body mass index; NA, not available
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living in rural Ghana and Ghanaians living in different sites
increased with age for both generalised obesity (Additional
file 2: Figure S2) and abdominal obesity (Additional file 3:
Figure S3). Figure 3 illustrates adjusted PRs for obesity
using rural Ghanaians as the reference category. For men,
the PR of obesity was five times higher in urban Ghanaians
than in their rural counterparts. Among Ghanaian
men living in Europe, the obesity PR increased 11- to
15-fold across all cities. For women, the PR of obesity
was four times higher in urban Ghanaians than in
rural dwellers. As for European cities, obesity PR in
Ghanaian women was increased up to 6.6-fold in
London. Similarly, the adjusted PRs of abdominal
obesity were higher in all sites than in rural Ghana,
although the difference between men in rural and
urban Ghana was statistically non-significant (Fig. 3).
When overweight and obesity were combined, 8 % of
men in rural Ghana were considered overweight or
obese, whereas this figure was nearly 40 % in urban
Ghana, 64 % in Berlin, 68 % in Amsterdam, and 75 % in
London (Additional file 4: Figure S4). In women, this
proportion was high even in rural Ghana (34 %), and
69 % in urban Ghana and 80–90 % in European cities
(Additional file 4: Figure S4).
Prevalence of type 2 diabetes and IFG
The age-standardised prevalence of type 2 diabetes in men
and women was 4 % and 6 %, respectively, in rural Ghana
(Fig. 4a, b). This proportion was higher in urban Ghana
(men, 10 %; women, 9 %) and in Europe, reaching its
maximum in Berlin (men, 15 %; women, 10 %). The
group-related differences increased with advancing age
(Additional file 5: Figure S5). Newly detected type 2 dia-
betes was more common in urban Ghana than in other
sites (Table 1). In addition, we observed a large proportion
of the participants with IFG in all sites including rural
Ghana (men, 13 %; women, 11 %; Fig. 5a, b). The
prevalence of IFG was particularly high in Amsterdam
(men, 32 %; women, 24 %) and significantly higher than
elsewhere. When rural Ghana was used as the reference
category, the PRs of type 2 diabetes in men were
nearly 3-fold higher in urban Ghana and increased to
Fig. 1 Age-standardised prevalence of obesity (BMI ≥ 30 kg/m2) by locality in men (a) and women (b). Error bars are 95 % confidence intervals
Fig. 2 Age-standardised prevalence of abdominal obesity (waist circumference, men: > 102 cm, women: > 88 cm) by locality in men (a) and
women (b). Error bars are 95 % confidence intervals
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nearly 4.5-fold higher in Berlin. In women, the PRs were
1.6-fold higher in London to 2-fold higher in the other
sites (Fig. 6).
The probability of type 2 diabetes increased with high
levels of BMI (Fig. 7a, b) and waist circumference (Fig. 8a,
b). However, with a given level of BMI and waist circumfer-
ence, the probability of type 2 diabetes was greater among
urban and migrant Ghanaians than their rural Ghanaian
peers in both men and women, although the magnitude of
the differences were greater in men than in women.
Discussion
Key findings
Our findings from a large, multi-centre and multi-
country study show higher rates of obesity and type 2
diabetes in urban Ghanaians and Ghanaian migrants in
Europe than in rural Ghana. For obesity, there was a
clear rising gradient in prevalence from rural through
urban Ghana to migrants in Europe. No such gradient
was observed for type 2 diabetes and IFG across the
sites. Notably, the difference in type 2 diabetes preva-
lence between urban Ghana and Ghanaians in Europe
was rather small. The prevalence of IFG was generally
high and similar across sites except for the even higher
prevalence in Amsterdam.
Strengths and limitations
The main strength of the RODAM study is the use of
well-standardised approaches across the various study
sites. Another unique strength of this study is the
Fig. 3 Prevalence ratios of obesity (BMI ≥ 30 kg/m2) and abdominal obesity by locality and sex (models are adjusted for age and education)
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homogenous study population of Ghanaians living in dif-
ferent settings in Africa and Europe. So far, only a few
studies have attempted to assess the potential role of mi-
gration on obesity and type 2 diabetes among African
populations by comparing native Africans with people of
African ancestry living in the Caribbean, UK and USA
[11, 12]. However, these studies were limited due to the
heterogeneous ancestry of populations who were trans-
ported out of Africa several centuries ago. This factor, as
well as genetic admixture primarily with European an-
cestry population groups, make it difficult to assess the
potential role of migration and its impact on health in
African populations [20]. Furthermore, these studies
were based on secondary data with different measure-
ment protocols. The RODAM study overcomes these
previous limitations by focusing on one population using
the same measurement procedures in all sites.
Our study also has limitations. First, as in most
epidemiological studies, type 2 diabetes was defined by a
single blood glucose measurement, which traditionally
would have to be confirmed. Second, although the same
methods were applied in all sites, the recruitment strat-
egies had to be adapted to suit the local circumstances
due to differences in registration systems. Ghanaian
participants in Amsterdam, for example, were drawn
from the Amsterdam Municipal Population register,
whereas London participants were drawn mainly from
Ghanaian organisations lists. It is possible that individ-
uals who were not on the lists of these organisations
differ in terms of sociodemographics, which might
somewhat affect the representativeness of Ghanaian
migrants in London and Berlin. In a non-response
analysis, men more often were non-respondents than
women in all sites except for Berlin. Non-respondents
were younger than respondents in all sites. Further, the
non-response analysis in Berlin revealed that the dis-
tribution of respondents and non-respondents across
Berlin city districts was fairly similar. Additionally, evi-
dence suggests that most Ghanaians in Europe are affili-
ated with Ghanaian organisations [13, 14], suggesting
that members within these organisations may be repre-
sentative of the Ghanaian population living in various
European countries. Therefore, although a certain level
of bias is likely, as in all population-based surveys, we
consider it unlikely that the differences in prevalence
rates between European sites are substantially biased by
the variations in sampling strategy. Finally, only fasting
plasma glucose was used to diagnose diabetes, which
Fig. 5 Age-standardised prevalence of impaired fasting glucose by locality in men (a) and women (b). Error bars are 95 % confidence intervals
Fig. 4 Age-standardised prevalence of type 2 diabetes by locality in men (a) and women (b). Error bars are 95 % confidence intervals
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may underestimate the prevalence of diabetes. Evidence
suggests that the 2-h plasma glucose value after a 75-g
oral glucose tolerance test diagnoses more people with
diabetes fasting plasma glucose.
Discussion of the key findings
Our current findings show that obesity is extremely
common among women at all study sites, including a
notable prevalence in rural settings. The prevalence rates
in men were less than half of those among women.
Despite the higher burden among urban populations,
overweight/obesity is rapidly increasing also in rural
communities in low- and middle-income countries,
especially among women, as our study clearly shows.
Therefore, the notion that overweight/obesity is affecting
typically the urban populations can no longer be sub-
stantiated [7, 8]. In fact, over a third of women in rural
Ghana were either overweight or obese. This corrobo-
rates recent findings in rural South African youth [21].
Rapid urbanisation and improved contact between rural
and urban settings due to infrastructure improvements
may be facilitating the transfer and introduction of
urban practices to rural settings with consequent
changes in diet, resulting in consumption of energy-
dense traditional or processed foods as seen in urban
Ghana and some settings in SSA [22, 23]. Of note, the
Adjusted PR of type 2 diabetes and impaired fasting glycaemia by locality and sex - RODAM study
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Fig. 6 Prevalence ratio of type 2 diabetes and impaired fasting glycaemia by locality and sex (models adjusted for age and education)
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present study shows that the obesity rate among women
in urban Ghana is nearly as high as those reported
among women in the USA [24], and far higher than the
prevalence rates reported among women in many
European high-income countries [25–27]. We show that
Ghanaian migrants in Europe are particularly affected by
obesity, the rate being up to 15 times higher than among
their rural counterparts in Africa. Among migrant
Ghanaian women, the obesity rate greatly exceeds the
figures of the host European populations in all three
European countries. In the 2013 Health Survey for
England, the prevalence of obesity among English
general population women was 24 % [25] compared with
54 % observed in the present study among Ghanaian mi-
grant women in London. Similarly, the prevalence of
obesity among Dutch women is 13 % [26] compared
with 49 % in Ghanaian migrant women in Amsterdam,
and 24 % in German women [27] compared with 39 %
among Ghanaian migrant women in Berlin.
Worryingly, type 2 diabetes occurred at a similar preva-
lence among individuals in urban Ghana and in Europe.
Previous studies among SSA populations found a rising
gradient of type 2 diabetes from SSA through the
Caribbean to the UK and USA [11, 12]. Mbanya et al.
[12], for example, reported an age-standardised prevalence
of diabetes of 1 % among urban Cameroonian men com-
pared with 15 % in African Caribbeans in the UK. This
gradient was due to extremely low prevalence of type 2
diabetes in SSA, which has been documented from the
earliest studies that were conducted more than five
decades ago. For example, in a 1958 study, Dodu et al.
[28] observed a diabetes prevalence of 0.4 % in an urban
population in Accra, Ghana. Likewise, a community-based
study in the Volta region of Ghana in 1964 found a
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Fig. 7 Probability of type 2 diabetes by BMI in men (a) and women (b) (models are adjusted for age)
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Fig. 8 Probability of type 2 diabetes by waist circumference in men (a) and women (b) (models are adjusted for age)
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diabetes prevalence of 0.2 % [29]. In contrast, the results
of the present study suggest that the gradient between
urban Africans and diaspora African living in high-income
European countries is fading rapidly. In fact, the preva-
lence of type 2 diabetes among women was marginally
higher in urban Ghana (9.2 %) than in London (8.4 %).
Thus, the increasing risk of type 2 diabetes is no longer an
issue of only migrant populations, but appears to have
reached urban communities in SSA. This implies in-
creased risks for rural African communities, especially
given the rapid changing lifestyles in these settings. The
rise of obesity and type 2 diabetes among SSA populations
can be partly attributed to modernisation with consequent
adoption of unhealthy aspects of globalised lifestyles such
as physical inactivity and poor dietary behaviour [22]. The
key specific drivers within these broad categories, how-
ever, still need to be identified. Interestingly, the preva-
lence of type 2 diabetes was higher in men than in women
despite the higher levels of obesity in women in all sites
except rural Ghana. The explanations for these differences
are unclear, but may be partly due to a more favourable
body fat distribution in women [30]. Alternatively, it is
possible that body weight has a larger impact on type 2
diabetes risk among men than among women, as is sug-
gested by the current study.
Another important finding from this study is the high
prevalence of IFG in all sites. The IFG rates in both rural
(12 %) and urban (13 %) Ghana are far higher than those
in most urban populations in Africa [31, 32]. In a
community-based study conducted more than a decade
ago in urban Accra, the IFG prevalence was 6.2 % [33], in-
dicating a nearly 110 % percentage increase in IFG in
urban Ghana in a decade. In the present study, IFG was
exceptionally common in Amsterdam Ghanaian migrants,
which is consistent with our earlier findings [10, 34, 35].
In a previous study, the prevalence of IFG was 35 % and
14 % among African Caribbeans in the Netherlands and in
England, respectively [34]. The high rate of IFG is worry-
ing given the increased risk of developing type 2 diabetes
and related complications [36]. The reasons for the abun-
dance of IFG among Ghanaians in the Netherlands is un-
clear but might be due to contextual factors such as
differences in treatment of diabetes and/or unknown
aetiological factors; this requires further study.
Despite varying prevalence rates among the host popu-
lations in the three European countries, the respective dif-
ferences among migrants residing in these countries were
rather small. Still, although higher, the type 2 diabetes
prevalence among the migrant populations mimics their
respective host European populations. Recent Inter-
national Diabetes Federation age-standardised estimates
indicate a prevalence of type 2 diabetes of 4.7 % in the
UK, 5.5 % in the Netherlands, and 7.4 % in Germany [1].
Despite the lower prevalence of type 2 diabetes in the UK
[25], obesity is more common in the UK than in most
European countries [26, 27]. Interestingly, a similar pat-
tern was observed among our study populations with
Ghanaians in London having a lower prevalence of type 2
diabetes but a higher prevalence of obesity compared with
Amsterdam and Berlin. This observation seems to suggest
that the national contextual factors, such as prevailing
health behaviour, health-related policies and access to pre-
ventive services, may influence metabolic risk factors in
different ways in various countries [6, 37].
Our findings have important public health implica-
tions for health planners in Europe and Africa. The
prevalence rates of obesity and type 2 diabetes among
African migrants exceed those of the European host
populations. Ghana is a lower middle-income country
with a substantial burden of communicable diseases.
The high levels of overweight and type 2 diabetes will
undoubtedly put more pressure on the already overbur-
dened health system suggesting an urgent need for ac-
tion with strong support by government and civil
societies in Ghana. This requires a health policy shift to-
wards prevention and control of obesity and diabetes
and other non-communicable diseases [38].
Conclusions
Our study findings show that obesity, IFG and type 2 dia-
betes are common in both SSA migrants and their popula-
tion of origin. The findings show a gradient of rising
prevalence from rural through urban Africa to Europe for
obesity, but not for the type 2 diabetes gradient between
urban African and Europe, which has reached almost
European levels in urban Ghana. This seems to suggest
that the increased risk of type 2 diabetes is no longer lim-
ited to migrant populations, and that processes similar to
those underlying the high burden in migrants may also be
at play in SSA, particularly in urban centres. This, in turn,
points to an urgent need to unravel the potential factors
contributing to the high prevalence of these conditions in
both SSA migrants and non-migrants to inform targeted
intervention and prevention programmes.
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